Exozymes (EXOZ) Capital Expenditures (2023 - 2025)
Exozymes (EXOZ) posted quarterly Capital Expenditures of $74988.0 for Q4 2025, down 64.36% year-over-year from $210406.0 in Q4 2024, and up 463.4% quarter-over-quarter from $13310.0 in Q3 2025.
Exozymes (EXOZ) Capital Expenditures (2023 - 2025) Analysis & Trends
Exozymes (EXOZ) has reported Capital Expenditures for 3 consecutive years, with $74988.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Capital Expenditures fell 64.36% year-over-year to $74988.0; the TTM figure through Dec 2025 stood at $169917.0 (down 57.14% YoY), while the FY2025 annual figure was $169917.0, down 57.14% from the prior year.
- Capital Expenditures grew to $74988.0 in Q4 2025 per EXOZ's latest filing, from $13310.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $210406.0 in Q4 2024 and bottomed at $13310.0 in Q3 2025.
- Historically, Capital Expenditures has averaged $84513.9 across 3 years, with a median of $62780.5 in 2025.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 91.73% — and 2025, when it plunged 79.14%.
- Exozymes' Capital Expenditures stood at $109743.0 in 2023, then surged by 91.73% to $210406.0 in 2024, then tumbled by 64.36% to $74988.0 in 2025.
- Business Quant data shows EXOZ's Capital Expenditures at $74988.0 in Q4 2025, $13310.0 in Q3 2025, and $50573.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Exozymes | 62.35 Mn | 62.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74,988.00 |
| Dec 31, 2025 | 74,988.00 |
| Sep 30, 2025 | 13,310.00 |
| Sep 30, 2025 | 13,310.00 |
| Jun 30, 2025 | 50,573.00 |
| Jun 30, 2025 | 50,573.00 |
| Mar 31, 2025 | 31,046.00 |
| Mar 31, 2025 | 31,046.00 |
| Dec 31, 2024 | 210,406.00 |
| Dec 31, 2024 | 210,406.00 |
| Jun 30, 2024 | 37,237.00 |
| Jun 30, 2024 | 37,237.00 |
| Mar 31, 2024 | 148,808.00 |
| Mar 31, 2024 | 148,808.00 |
| Dec 31, 2023 | 109,743.00 |
| Dec 31, 2023 | 109,743.00 |